期刊文献+

稳定期重症肌无力患者的睡眠质量及其影响因素的研究 被引量:2

Study of sleep quality and influence factors in patients with stable myasthenia gravis
原文传递
导出
摘要 目的探讨稳定期重症肌无力(MG)患者睡眠质量及影响因素。方法采用匹兹堡睡眠质量指数(PSQI)评价2015年9月至2017年2月四川大学华西医院神经内科门诊收治的151例稳定期MG患者的睡眠质量,Spearman相关分析影响因素(临床资料、生活质量、焦虑、抑郁)。结果 Spearman分析示患者年龄、病程、重症肌无力生存质量量表(MG-QOL15)、汉密尔顿焦虑量表(HAMA14)、汉密尔顿抑郁量表(HADA24)与PSQI总分呈正相关。行逐步线性回归发现低水平生活质量为MG患者低质量睡眠的最佳预测因子(t=3.161,P=0.002),接着是抑郁(t=2.495,P=0.014)、年龄(t=2.356,P=0.020)。结论稳定期MG患者睡眠质量的的影响因素较多,应予以重视。 Objective To investigate the sleep quality and influencing factors in patients with stable myasthenia gravis (MG). Methods From September 2015 to February 2017, 151 cases of stable MG were enrolled in the department of neurology, West China Hospital, Pittsburgh sleep quality index (PSQI) was used to evaluate their sleep quality; Spearman analysis was used to analyze the influencing factors (clinical data, quality of life, anxiety and depression). Results Spearman test analysis showed that PSQI was positively correlated with age, duration, myasthenia gravis quality of life 15 (MG-QOL15), Hamilton Anxiety Scale 14 ( HAMA14 ) , Hamilton Depression Scale 24 ( HADA24 ) ( P 〈 0.05 ). Stepwise regression analysis further revealed that life quality was the best predictor of reduced sleep quality ( t = 3. 161, P = 0. 002), followed by anxiety ( t = 2. 495, P = 0. 014) and age ( t = 2. 356, P = 0. 020 ). Conclusions There are many influencing factors of stable MG wnich more attentions should be paid on .
作者 冯惠茹 刘举 陈红西 石紫燕 连志云 杜琴 周红雨 Feng Huiru, Liu Ju, Chen Hongxi, Shi Ziyan, Lian Zhiyun, Du Qin, Zhou Hongyu(Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China)
出处 《中国医师杂志》 CAS 2018年第3期352-356,共5页 Journal of Chinese Physician
基金 国家自然科学基金(81271321) 四川省科技厅项目(2013FZ0015) 中央高校基本科研专项资金(2017SCU11049)~~
关键词 重症肌无力/并发症 睡眠障碍/并发症 生活质量 Myasthenia gravis/CO Sleep disorders/CO Quality of life
  • 相关文献

参考文献4

二级参考文献129

  • 1刘卫彬,门丽娜,何雪桃,夏强,黄如训.我国南方1520例重症肌无力患者的临床特点[J].中国神经免疫学和神经病学杂志,2006,13(6):326-330. 被引量:39
  • 2彭丹涛,许贤豪,佘子瑜.新斯的明试验改良结果判定法研究[J].中国神经免疫学和神经病学杂志,2007,14(1):1-3. 被引量:26
  • 3Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis:past, present, and future[J]. J Clin Invest, 2006, 116(11):2843-2854.
  • 4Besinger VA, Toyka KV, Hiimberg M, et al. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking anti?bodies against acetylcholine receptors with changes in disease se?verity[J]. Neurology, 1983,33(10):1316-1321.
  • 5Tindall RSA, Rollins JA, Phillips JT, et al. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclospo?rine in myasthenia gravis[J]. N Engl J Med, 1987, 316(11): 719-724.
  • 6Barohn RJ, McIntire D, Herbelin L, et al. Reliability testing of the quantitative myasthenia gravis score[J]. Ann NY Acad Sci, 1998,841:769-772.
  • 7Bedlack RS, Simel DL, Bosworth H, et al. Quantitative myasthe?nia gravis score: assessment of responsiveness and longitudinal validity[J]. Neurology, 2005, 64(11):1968-1970.
  • 8Sanders DB, Tucker-Lipscomb B, Massey JM. A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score[J]. Ann N Y Acad Sci, 2003, 998:440-444.
  • 9Jaretzki A, Barohn RJ, Ernstoff RM, et al. Myasthenia Gravis: recommendations for clinical research standards[J]. Neurology, 2000,55(1):16-23.
  • 10Farrugia ME, Robson MD, Clover L, et al. MRI and clinical stud?ies of facial and bulbar muscle involvement in MuSK anti?body-associated myasthenia gravis[J]. Brain, 2006, 129(6): 1481-1492.

共引文献294

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部